HealthCare Global Enterprises Limited Announces Board Meeting for FY26 Financial Results
HealthCare Global Enterprises Limited has notified the National Stock Exchange of India Limited and BSE Limited about an upcoming Board meeting scheduled for Tuesday, May 19, 2026. The meeting will consider and approve the audited financial results, both standalone and consolidated, for the quarter and financial year ended March 31, 2026. In compliance with SEBI regulations, the trading window for designated persons and their immediate relatives has been closed since April 1, 2026, and will remain closed until 48 hours after the declaration of the financial results.

*this image is generated using AI for illustrative purposes only.
HealthCare Global Enterprises Limited has notified the National Stock Exchange of India Limited and BSE Limited about an upcoming Board meeting scheduled for Tuesday, May 19, 2026. The meeting has been convened to consider and approve, among other matters, the audited financial results of the company for the quarter and financial year ended March 31, 2026. The financial results will include both standalone and consolidated statements.
Key Meeting Details
| Particulars | Details |
|---|---|
| Meeting Date | May 19, 2026 |
| Day | Tuesday |
| Agenda | Audited Financial Results (Standalone and Consolidated) |
| Financial Period | Quarter and year ended March 31, 2026 |
| BSE Stock Code | 539787 |
| NSE Stock Code | HCG |
Trading Window Closure
In accordance with the company's code of conduct framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the company has been closed for all designated persons and their immediate relatives. The closure period commenced on April 1, 2026, and shall remain closed until 48 hours after the declaration of the financial results.
Regulatory Reference
The intimation has been made in reference to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested the exchanges to take this intimation on record. The information is also available on the company's official website at https://www.hcgoncology.com/ .
How might HealthCare Global's FY2026 financial results impact its expansion plans in the oncology and healthcare services sector?
What strategic initiatives or acquisitions could the company announce following the board meeting approval of financial results?
Will the company's performance influence its dividend policy or capital allocation strategy for the upcoming fiscal year?

































